Redirecting to https://www.businesswire.com/news/home/20260604316661/en/Otsuka-Presents-Positive-Interim-Phase-3-VISIONARY-eGFR-Data-Showing-VOYXACT-sibeprenlimab-szsi-Preserved-Kidney-Function-Over-12-Months-in-IgA-Nephropathy-IgAN